Keros Therapeutics, Inc. (KROS)
11.10
-0.08
(-0.67%)
USD |
NASDAQ |
Sep 11, 16:00
11.10
0.00 (0.00%)
After-Hours: 18:37
Keros Therapeutics Gross Profit (TTM) : 13.41M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.41M |
| March 31, 2026 | 31.61M |
| December 31, 2025 | 242.55M |
| September 30, 2025 | 245.28M |
| June 30, 2025 | 231.48M |
| March 31, 2025 | 213.42M |
| December 31, 2024 | 2.321M |
| September 30, 2024 | -0.493M |
| June 30, 2024 | -1.11M |
| March 31, 2024 | -1.386M |
| December 31, 2023 | -1.881M |
| September 30, 2023 | -2.225M |
| June 30, 2023 | -2.019M |
| March 31, 2023 | -1.988M |
| December 31, 2022 | -1.615M |
| Date | Value |
|---|---|
| September 30, 2022 | 18.53M |
| June 30, 2022 | 18.64M |
| March 31, 2022 | 19.16M |
| December 31, 2021 | 19.30M |
| September 30, 2021 | -0.575M |
| June 30, 2021 | -0.473M |
| March 31, 2021 | -0.632M |
| December 31, 2020 | -0.605M |
| September 30, 2020 | -0.432M |
| June 30, 2020 | -0.311M |
| March 31, 2020 | -0.152M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Incyte Corp. | 5.320B |
| Viking Therapeutics, Inc. | -0.45M |
| Nurix Therapeutics, Inc. | 19.51M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |